Samrat Pharmachem Share Price

Samrat Pharmachem

CMP as on18-May-22 15:29

₹ 402.35
9.85 2.51%

Open

₹ 373.00

Turnover (lac)

₹ 12

Prev. Close

₹ 392.50

Day's Vol (shares)

₹ 867

Day's Range

₹ 373.00
₹ 411.60

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 28-Dec-2021 - -
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 inter alia to consider and approve the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended December 31 2021. The Company shall intimate to the exchanges the Un-Audited financial results upon the conclusion of the aforesaid Board Meeting and will arrange for the announcement of the same in the Press and on the companys website as required under the Listing Agreement. (As Per BSE Announcement Dated on 10/02/2022)
Board Meeting - 28-Sep-2021 - -
Quarterly Results We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, November 13, 2021, the Board has considered and took on record the Un-Audited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2021, which is enclosed herewith along with the Statement of Asset & Liabilities, Cash Flow Statement and the Limited Review Report of the Statutory Auditor of the Company. The meeting of the Board of Directors of the Company commenced at 13:00 hrs and concluded at 14:00 hrs. (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 06-Jul-2021 - -
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held at 01:00 P.M. on Friday, the 13th day of August, 2021 at the Corporate Office of the Company at 701/702, Business Square, M. A. Road, Andheri (West), Mumbai - 400 058, inter alia, to consider and take on record the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended June 30, 2021. The Company shall intimate to the exchanges the Un-Audited financial results upon the conclusion of the aforesaid Board Meeting and will arrange for the announcement of the same in the Press and on the companys website as required under the Listing Agreement. We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Friday, August 13, 2021, the Board has considered and took on record the attached Un-Audited Standalone Financial Results of the Company for the quarter ended June 30, 2021, which is enclosed herewith along with the Limited Review Report of the Statutory Auditor of the Company. The meeting of the Board of Directors of the Company commenced at 13:00 hrs and concluded at 14:45 hrs. (As Per BSE Announcement dated on 13.08.2021)
Board Meeting - 07-Jun-2021 - -
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve the Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the year ended March 31, 2021. The Company shall intimate to the exchanges the Audited financial results upon the conclusion of the aforesaid Board Meeting and will arrange for the announcement of the same in the Press and on the companys website as required under the Listing Agreement. We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, June 30, 2021, the Board has considered and adopted the attached Audited Financial Results of the Company for the year ended March 31, 2021, which is enclosed herewith along with the Statement of Assets and Liabilities, Cash Flow Statement, Auditors Report and Declaration for Unmodified Opinion on the Financial Results of the Company. The meeting of the Board of Directors of the Company commenced at 14:00 hrs and concluded at 16:00 hrs. (As per BSE Announcement Dated on 30/06/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity